At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 144 enrolled
Drug / intervention
122-0551 Foam +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 122-0551 Foam Versus Vehicle Foam in Subjects With Plaque Psoriasis
In Brief
A Phase 3 clinical trial evaluating 122-0551 Foam and Vehicle Foam for Plaque Psoriasis. Completed, enrolled 144 participants across 9 sites.
Detailed Summary
This Phase 3 study has been designed to determine and compare the efficacy and safety of 122-0551 Foam and Vehicle Foam applied twice daily for two weeks in subjects with plaque psoriasis.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPlaque Psoriasis
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartJan 2015
First PostedFeb 2015
Primary CompletionAug 2015
Study CompletionFeb 2017
TodayJul 2026
First PostedFeb 20, 2015
Enrollment StartJan 1, 2015
Primary CompletionAug 1, 2015
Study CompletionFeb 1, 2017
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 11.4 years ago
Interventions
122-0551 Foamdrug
122-0551 Foam applied twice daily to treat psoriasis
Vehicle Foamdrug
Vehicle Foam applied twice daily to treat psoriasis